314 related articles for article (PubMed ID: 16450574)
21. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
[TBL] [Abstract][Full Text] [Related]
23. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Prenner B; Anolik R; Danzig M; Yao R
Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
Meltzer EO; Casale TB; Gold MS; O'Connor R; Reitberg D; del Rio E; Weiler JM; Weiler K
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
[TBL] [Abstract][Full Text] [Related]
28. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
29. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
Crampton HJ
Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
[TBL] [Abstract][Full Text] [Related]
30. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
31. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis.
Nayak AS; Schenkel E
Allergy; 2001 Nov; 56(11):1077-80. PubMed ID: 11703222
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR
Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
34. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
Pradalier A; Neukirch C; Dreyfus I; Devillier P
Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
[TBL] [Abstract][Full Text] [Related]
35. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
[TBL] [Abstract][Full Text] [Related]
36. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit.
Horak F; Stübner UP; Zieglmayer R; Harris AG
J Allergy Clin Immunol; 2002 Jun; 109(6):956-61. PubMed ID: 12063524
[TBL] [Abstract][Full Text] [Related]
37. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
Simons FE; Prenner BM; Finn A;
J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
40. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
Dizdar EA; Sekerel BE; Keskin O; Kalayci O; Adalioglu G; Dogan C; Tuncer A
Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
